Please Wait.....
Report
Drug Discovery Services Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Process (Target Selection and Validation, Hit to Lead Identification, and Others), Type (Biology Services, Medicinal Chemistry, and Drug Metabolism and Pharmacokinetics), Molecule Type (Biologics and Small Molecules), Therapeutic Area (Cardiovascular Diseases, Oncology, Neurology, Diabetes, Respiratory Diseases, and Others), End User (Pharmaceutical and Biotechnology Companies, Academic Institutes, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Market Report I 2023-11-17 I 150 Pages I The Insight Partners
The drug discovery services market is expected to grow from US$ 19.539 billion in 2022 to US$ 56.783 billion by 2030; it is anticipated to record a CAGR of 14.3% from 2022 to 2030.
Drug discovery is the process of identifying and developing new medications to treat diseases and improve human health. It involves the identification of potential drug candidates, their synthesis and testing in laboratory and animal models, and ultimately, their evaluation in clinical trials in humans. Drug discovery services work by providing a range of specialized expertise and resources to support the drug discovery process. This can include medicinal chemistry, computational modeling, high-throughput screening, and preclinical testing services. These services are often provided by contract research organizations (CROs) or academic research institutions. Pharmaceutical companies and biotechnology firms use them to accelerate the drug discovery process and bring new medications to market more efficiently.
The increasing prevalence of chronic diseases drives the growth of the drug discovery services market.
The increasing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases, and respiratory diseases is creating a significant demand for discovery services in the healthcare industry. According to data published by the CDC in 2022, in the US, there will be around 37.3 million people with diabetes, which is 11.3% of the US population. As the prevalence of chronic and complex diseases continues to rise, there is a growing need for innovative treatments that can address unmet medical needs and improve patient outcomes. Furthermore, an increasing number of people are in their 60s and beyond due to increases in life expectancy. The number of older individuals worldwide is expected to increase from 727 million in 2020 to 1.5 billion by 2050, according to the United Nations Database on World Population Ageing 2020. The older population is more vulnerable to chronic illnesses, which increases demand for the chronic disease management sector. The rise in sedentary behavior would greatly impact the market for drug discovery services. Drug discovery services play an important role in the development of new drugs and medical technologies. They help pharmaceutical companies and research institutions identify and validate potential drug targets, conduct preclinical studies, and optimize drug candidates for clinical trials. This is essential for bringing new and effective treatments to market addressing the growing burden of chronic diseases.
In addition, the growing focus on personalized medicine and precision medicine has further fueled the demand for discovery services. Companies are increasingly seeking to develop tailored treatments for individual patients based on their genetic makeup and other factors. This personalized approach to medicine requires extensive research and discovery services to identify the most effective treatments for each patient's unique needs. Thus, the discovery services market is expected to continue to grow as the healthcare industry works to address the rising burden of chronic diseases and improve patient outcomes. The demand for these services is likely to remain strong as the need for innovative treatments and personalized medicine continues to drive research and development in the healthcare sector.
The drug discovery services market is divided on the basis of process, type, molecule type, therapeutic area, and end user. Based on the process, the drug discovery services market is segmented into target selection and validation, hit to lead identification, and others - assay development and screening, etc. By type, the drug discovery services market is segmented into biology services, medicinal chemistry drug metabolism, and pharmacokinetics. In terms of molecule type, the drug discovery services market is classified as biologics and small molecules. On the basis of therapeutic areas, the drug discovery services market is differentiated into cardiovascular diseases, oncology, neurology, diabetes, respiratory diseases, and others. Furthermore, the end-user segment is classified into Pharmaceutical and Biotechnology Companies, Academic Institutes, and Others.
Based on geography, the drug discovery services market is divided into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America is the most significant contributor to the growth of the drug discovery services market. This region's growth has been attributed to a number of factors, including an increase in the investments made by drug development companies, large grants from the US government, a strong presence of major drug development companies, a well-developed healthcare infrastructure, and an increase in chronic diseases.
As per the American Cancer Society's "Cancer Facts & Figures 2022," it is projected that by the conclusion of 2022, there will be around 1,918,030 new cancer cases and 609,360 cancer-related deaths in the United States. Given the high rate of cancer in this area, it is expected that the search for cancer drugs will accelerate market expansion. Additionally, the drug discovery market in this region is anticipated to be driven by the surge in technical breakthroughs in drug discovery in the United States. For example, CytoReason and Pfizer signed a multi-year cooperation in September 2022 so that Pfizer could use CytoReason's artificial intelligence technology for medication development. The adoption of AI technology in drug discovery by major US market players is anticipated to propel the expansion of the market under study in this area...
Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA), are a few key primary and secondary sources referred to while preparing the report on the drug discovery services market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Drug Discovery Services Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Drug Discovery Services Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Drug Discovery Services Market - Global Market Analysis
6.1 Drug Discovery Services - Global Market Overview
6.2 Drug Discovery Services - Global Market and Forecast to 2030
7. Drug Discovery Services Market - Revenue Analysis (USD Million) - By Process, 2020-2030
7.1 Overview
7.2 Target Selection and Validation
7.3 Hit To Lead Identification
7.4 Others
8. Drug Discovery Services Market - Revenue Analysis (USD Million) - By Type, 2020-2030
8.1 Overview
8.2 Biology Services
8.3 Medicinal Chemistry
8.4 Drug Metabolism and Pharmacokinetics
9. Drug Discovery Services Market - Revenue Analysis (USD Million) - By Molecule Type, 2020-2030
9.1 Overview
9.2 Biologics
9.3 Small Molecules
10. Drug Discovery Services Market - Revenue Analysis (USD Million) - By Therapeutic Area, 2020-2030
10.1 Overview
10.2 Cardiovascular Diseases
10.3 Oncology
10.4 Neurology
10.5 Diabetes
10.6 Respiratory Diseases
10.7 Others
11. Drug Discovery Services Market - Revenue Analysis (USD Million) - By End User, 2020-2030
11.1 Overview
11.2 Pharmaceutical and Biotechnology Companies
11.3 Academic Institutes
11.4 Others
12. Drug Discovery Services Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis
12.1 North America
12.1.1 North America Drug Discovery Services Market Overview
12.1.2 North America Drug Discovery Services Market Revenue and Forecasts to 2030
12.1.3 North America Drug Discovery Services Market Revenue and Forecasts and Analysis - By Process
12.1.4 North America Drug Discovery Services Market Revenue and Forecasts and Analysis - By Type
12.1.5 North America Drug Discovery Services Market Revenue and Forecasts and Analysis - By Molecule Type
12.1.6 North America Drug Discovery Services Market Revenue and Forecasts and Analysis - By Therapeutic Area
12.1.7 North America Drug Discovery Services Market Revenue and Forecasts and Analysis - By End User
12.1.8 North America Drug Discovery Services Market Revenue and Forecasts and Analysis - By Countries
12.1.8.1 United States Drug Discovery Services Market
12.1.8.1.1 United States Drug Discovery Services Market, by Process
12.1.8.1.2 United States Drug Discovery Services Market, by Type
12.1.8.1.3 United States Drug Discovery Services Market, by Molecule Type
12.1.8.1.4 United States Drug Discovery Services Market, by Therapeutic Area
12.1.8.1.5 United States Drug Discovery Services Market, by End User
12.1.8.2 Canada Drug Discovery Services Market
12.1.8.2.1 Canada Drug Discovery Services Market, by Process
12.1.8.2.2 Canada Drug Discovery Services Market, by Type
12.1.8.2.3 Canada Drug Discovery Services Market, by Molecule Type
12.1.8.2.4 Canada Drug Discovery Services Market, by Therapeutic Area
12.1.8.2.5 Canada Drug Discovery Services Market, by End User
12.1.8.3 Mexico Drug Discovery Services Market
12.1.8.3.1 Mexico Drug Discovery Services Market, by Process
12.1.8.3.2 Mexico Drug Discovery Services Market, by Type
12.1.8.3.3 Mexico Drug Discovery Services Market, by Molecule Type
12.1.8.3.4 Mexico Drug Discovery Services Market, by Therapeutic Area
12.1.8.3.5 Mexico Drug Discovery Services Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
12.2 Europe
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 Spain
12.2.5 United Kingdom
12.2.6 Rest of Europe
12.3 Asia-Pacific
12.3.1 Australia
12.3.2 China
12.3.3 India
12.3.4 Japan
12.3.5 South Korea
12.3.6 Rest of Asia-Pacific
12.4 Middle East and Africa
12.4.1 South Africa
12.4.2 Saudi Arabia
12.4.3 U.A.E
12.4.4 Rest of Middle East and Africa
12.5 South and Central America
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Rest of South and Central America
13. Pre and Post Covid-19 Impact
14. Industry Landscape
14.1 Mergers and Acquisitions
14.2 Agreements, Collaborations, Joint Ventures
14.3 New Product Launches
14.4 Expansions and Other Strategic Developments
15. Competitive Landscape
15.1 Heat Map Analysis by Key Players
15.2 Company Positioning and Concentration
16. Drug Discovery Services Market - Key Company Profiles
16.1 Abbott Laboratories
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
Note - Similar information would be provided for below list of companies
16.2 Agilent Technologies
16.3 Ubiquigent
16.4 Albany Molecular Research Inc.
16.5 AstraZeneca PLC
16.6 Aurigene
16.7 Bayer AG
16.8 Charles River Laboratories International
16.9 ChemBridge Corporation
16.10 Covance
17. Appendix
17.1 Glossary
17.2 About The Insight Partners
17.3 Market Intelligence Cloud
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security